| Not Yet Recruiting | SuperCAP Program to Improve Cognition and Daily Functioning in Post-COVID-19 Condition Post COVID Condition | N/A | 2026-04-01 |
| Active Not Recruiting | Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG - Second Trial Cutaneous Ulcer Disease, Skin Sores | Phase 2 | 2025-11-03 |
| Recruiting | Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts Mpox (Monkeypox) | — | 2025-10-31 |
| Active Not Recruiting | Safety and Impact of Baricitinib on Cell Surivival Pathways, HIV-1 Reservoir and Inflamation in People With HI HIV | Phase 2 | 2025-09-22 |
| Recruiting | Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients COVID - 19, Renal Transplant, SARS CoV 2 Infection | Phase 2 | 2025-09-01 |
| Recruiting | Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC) Post COVID-19 Condition, Long COVID Syndrome, Persistent COVID-19 | Phase 2 | 2025-02-07 |
| Active Not Recruiting | A Single-center, Self-controlled, Prospective Case Series Pilot Study to Assess the Effect of Lamivudine (3TC) Mild Cognitive Impairment | Phase 2 | 2024-10-28 |
| Recruiting | Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique HIV, HIV Antiretroviral Therapy (ART) Adherence | — | 2024-10-25 |
| Completed | Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG Cutaneous Ulcer Disease, Skin Sores | Phase 2 | 2024-10-04 |
| Completed | Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Lon HIV-1-infection | N/A | 2024-07-16 |
| Completed | Supervised Computerized Active Program for People With Post-COVID Syndrome (SuperCAP Study) Post-COVID Condition | N/A | 2023-10-03 |
| Completed | Implementation of Out-of-HOspital Administration of the Long-Acting Cabotegravir+Rilpivirine HIV-1 Infection | Phase 4 | 2023-09-26 |
| Completed | Repurposing Clinically Approved Drugs for Yaws with an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep Yaws, Cutaneous Ulcer | Phase 3 | 2023-03-14 |
| Completed | Plasma Exchange Therapy for Post- COVID-19 Condition: A Pilot, Randomized Double-Blind Study Post-COVID19 Condition | Phase 2 | 2022-09-22 |
| Recruiting | Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Monkeypox | — | 2022-09-14 |
| Completed | Break-through Infection Following Mpox vaccinatIon Mpox | — | 2022-09-12 |
| Completed | Viral Clearance and Epidemiological Characteristics in Patients With Monkeypox Monkeypox | — | 2022-06-28 |
| Active Not Recruiting | Alternative Antibiotics for Syphilis Early Latent Syphilis, Primary Syphilis, Secondary Syphilis | Phase 3 | 2021-10-14 |
| Completed | Rapid Screening Circuit of COVID 19 in Schools, Pilot Study SARS-CoV-2 (COVID-19) | N/A | 2021-04-22 |
| Completed | Incidence of Infection Reported by COVID-19 in Attendees of a Commercial Music Concert Covid-19 (SARS-CoV-2) | — | 2021-03-27 |
| Completed | Removal of Doravirine by Hemodialysis in HIV-Infected Patients With End-stage Renal Disease (ESRD) HIV-infected Participants With ESRD Undergoing Routine Hemodialysis | Phase 4 | 2021-03-20 |
| Completed | Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musi COVID-19 (SARS-CoV-2) | N/A | 2020-11-30 |
| Completed | Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients SARS-CoV-2 Infection, Safety and Efficacy | Phase 2 | 2020-11-10 |
| Completed | Study to Assess the Safety and Durability of Viral Control Beyond 24 Weeks of Analytical Treatment Interruptio HIV-1 Infection | Phase 1 | 2020-06-01 |
| Completed | Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel SARS-CoV-2 Infection | — | 2020-05-26 |
| Completed | Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention COVID-19 | Phase 3 | 2020-03-18 |
| Completed | Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals HIV-1-infection | Phase 2 | 2020-02-18 |
| Completed | Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals HIV-1-infection | Phase 3 | 2020-02-18 |
| Completed | Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat Pharmacokinetic Interactions, HIV | Phase 1 | 2020-01-30 |
| Completed | EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED HIV-1 Infection | Phase 4 | 2018-11-19 |
| Completed | Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Ch HIV | Phase 3 | 2017-07-28 |
| Completed | Pilot Study to Assess the Impact of a Mobile Health Application (App) on Clinical Outcomes and Satisfaction of HIV-1 Infection | N/A | 2016-12-15 |
| Completed | Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected HIV-1 Infection | Phase 1 | 2016-06-01 |
| Completed | Study to Assess the ART Impact on the Brain Outcomes. The ARBRE Study HIV-1 Infection, Cognitive Impairment | — | 2015-10-26 |
| Completed | Study of the Effect of Atorvastatin for Reducing Aging-related Complication in HIV-infected Patients Older Tha Aging-related Inflammation in HIV-infected Patients | Phase 4 | 2015-10-15 |
| Completed | Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease HIV | Phase 4 | 2015-06-01 |
| Completed | Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Protease Inhibitors To Dolutegr HIV-1 Infection | Phase 3 | 2014-01-01 |
| Completed | First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal M HIV | Phase 1 | 2012-10-01 |
| Completed | Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1 HIV, Dyslipidemia | Phase 4 | 2012-01-01 |
| Completed | Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV HIV | Phase 4 | 2011-06-01 |
| Completed | Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT- Neurocognitive Disturbance, HIV Infection | Phase 4 | 2011-05-01 |
| Completed | Drug Interactions Between Echinacea Purpurea and Etravirine HIV | N/A | 2011-04-01 |
| Completed | Drug Interactions Between Silimarine and Darunavir/Ritonavir HIV | Phase 4 | 2011-03-01 |
| Completed | Antiretroviral Resistance Detection by Ultrasensitive Pyrosequencing of the HIV-1 Genome and Virological Respo HIV | — | 2010-07-01 |